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Supplementary Figure S1 . Statistical analysis of the miRNA microarray in a cohort study.
(A) As identified by ANOVA analysis of 4 groups, 17 miRNAs (6 upregulated miRNAs and 11 downregulated miRNAs in non-responder's tumors) exhibited significant expression changes.
(B) As identified by quantitative RT-PCR (qRT-PCR) of tumor samples from the two groups, 5 miRNAs (miR-197, miR-181c, miR-21, miR-210 , and miR-1260) exhibited significant expression changes. (C) Overall survival Kaplan-Meier curves were based on miR-197 or miR-1260 expression; median miRNA expression was used to define low and high expressers (miR-197; p=0.014, miR-1260; p=0.037) . Experiments were repeated at least three times with similar results, and error bars represent the mean ± SD, *p<0.05. **p< 0.01. NC, negative control.
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Supplementary Figure S5. Western blot analyses of the downstream targets of CKS1B.
siRNA-mediated knockdown of CKS1B inhibited phosphorylated (p)-STAT3 (Tyr705) and PD-L1 protein expression with no remarkable effect on STAT3 in western blots using β-actin as an internal control. Experiments were repeated at least three times with similar results. Figure S6 . FCM analyses of the PD-L1 levels of A549, PC14, and PC14CDDP. The PD-L1 + cell level analyses by FCM of A549 (5.5 ± 0.2%), PC14 (2.6 ± 0.3%), and PC14CDDP (51.8 ± 1.2%) (mean ± SD). Experiments were repeated at least three times with similar results. hsa-miR-21, hsa-miR-142-3p, hsa-miR-181c, hsa-miR-182, hsa-miR-210, hsa-miR-1260 Downregulated miRNAs in non-responder's tumors; hsa-miR-29c, hsa-miR-30a*, hsa-miR-30e*, hsa-miR-126, hsa-miR-139-5p, hsa-miR-144, hsa-miR-197, hsa-miR-338-3p, hsa-miR-497, hsa-miR-663b, hsa- Tumor""""""""""""""""""""""" Tumor""""""""""""""""""""""" (Non5responder)" miR-142-3p p=0.402 0"
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